This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: The Innovations of Patrick Breen
Introduction
Patrick Breen is an accomplished inventor based in Dorado, Puerto Rico. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes that enhance drug formulation. His work has been instrumental in advancing treatments for hypertension and congestive heart failure.
Latest Patents
One of Patrick Breen's notable patents is the "Process for the crystallization of losartan." Losartan potassium is an angiotensin II antagonist that plays a crucial role in treating hypertension and congestive heart failure. This invention focuses on the controlled crystallization of losartan potassium through anti-solvent addition combined with massive seeding. This method aims to achieve the desired crystal morphology and bulk physical properties necessary for successful formulation.
Career Highlights
Patrick Breen is associated with Merck & Co., Inc., a leading global healthcare company. His work at Merck has allowed him to contribute to innovative solutions in the pharmaceutical industry. With a patent portfolio that includes one patent, he has demonstrated his ability to address complex challenges in drug formulation.
Collaborations
Throughout his career, Patrick has collaborated with esteemed colleagues, including Karen A. Larson and Albert D. Epstein. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
In summary, Patrick Breen is a notable inventor whose work in the crystallization of losartan potassium has made a significant impact in the pharmaceutical field. His contributions continue to influence the development of effective treatments for critical health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
